Rapid Cool: Heat Stroke Treatment
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
Hot climates such as in Phoenix, AZ commonly have individuals experiencing heat stroke, a life-threatening medical emergency. The dangerously high body temperature can result in death if not treated immediately with rapid body cooling. Rapid core temperature reduction within 30 min of diagnosis results in 100% survival and positive outcomes. While this is easily achieved with whole-body cold water immersion, this modality is not feasible in an ambulance. The Phoenix emergency medical services protocol consists of lying the patient on a large volume of ice. While this is somewhat effective, this cooling strategy results in a sub-optimal cooling rate, difficulty obtaining this large volume of ice, and a very wet ambulance as the ice melts. Recently, a company created a cooling strategy that utilizes a small amount of ice and a small amount of recirculated water to keep the patient cool. The purpose of this study is to determine the core temperature cooling rate of this cooling strategy and compare it to the cooling rate of the currently used Phoenix protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2026
CompletedFirst Posted
Study publicly available on registry
August 4, 2026
CompletedStudy Start
First participant enrolled
September 21, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2027
Study Completion
Last participant's last visit for all outcomes
August 31, 2027
August 4, 2026
July 1, 2026
11 months
July 30, 2026
July 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cooling Rate
Internal body temperature reduction throughout cooling
30 minutes post-exercise
Study Arms (2)
Phoenix Protocol First
ACTIVE COMPARATORTraditional cooling with ice and water trial first, followed by Recirculated water trial
Recirculated Cooling First
EXPERIMENTALRecirculated water trial first, followed by Traditional cooling with ice and water trial
Interventions
Participants will lie in a thick plastic bag with ice and water, placed on top of a cot, with the water circulated using a pump
Participants will lie in a thick plastic bag filled with ice and water, placed on top of a cot
Eligibility Criteria
You may qualify if:
- Adult participant (18 - 39 years old)
- Body mass index (BMI) 18 - 30 kg/m2
- At least moderate intensity aerobic exercise ≥60 min per week
- Participant is able and willing to follow study procedures
You may not qualify if:
- History of cardiovascular, neurological, metabolic, pulmonary, renal, gastrointestinal, or autoimmune disease
- Taking prescription medication (with exception of psychiatric medication)
- If taking a psychiatric medication, the dosage has changed within the month prior to first study visit
- Cannot abstain from taking over-the-counter medications or supplements for 24 hours before study visits (with exception of vitamins)
- Resting systolic blood pressure ≥130 mmHg and/or diastolic blood pressure ≥90 mmHg
- Resting heart rate of ≥100 beats per minute
- Regular smoker of cigarettes or has regularly smoked in the past year
- Musculoskeletal injury/condition that negatively impacts the protocol
- History of heat illness that resulted in a visit to a medical center in the past 2 years
- Has donated blood or plasma in the past 3 months
- Has taken antibiotics or corticosteroids within 4 weeks of enrollment
- Has a medical implant device such as a pacemaker, patient monitoring system, or metallic implant
- Has a full or partially amputated limb
- Pregnant or breastfeeding
- Study physician or PI discretion based on any other medical condition or medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 30, 2026
First Posted
August 4, 2026
Study Start (Estimated)
September 21, 2026
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
August 31, 2027
Last Updated
August 4, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
A spreadsheet of the cleaned, coded data for all variables will be shared with researchers upon reasonable written request. In addition to the dataset, a study protocol, data dictionary defining the variables, and data collection instruments can be shared.